PREMIER ASSET MANAGEMENT LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.

Quarter-by-quarter ownership
PREMIER ASSET MANAGEMENT LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2021$217,000
-27.4%
51,305
-33.3%
0.04%
-36.1%
Q4 2020$299,000
+139.2%
76,934
+157.6%
0.06%
+17.3%
Q1 2020$125,00029,8650.05%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,914,970$81,007,00029.87%
RTW INVESTMENTS, LP 1,080,331$30,022,0009.33%
Avoro Capital Advisors LLC 804,299$22,351,0005.81%
ACUTA CAPITAL PARTNERS, LLC 122,222$3,397,0001.97%
Broadfin Capital, LLC 1,095,373$30,440,0001.69%
Belmont Global Advisors, Inc. 35,000$973,0001.65%
P.A.W. CAPITAL CORP 48,000$1,334,0001.53%
Perceptive Advisors 1,309,030$36,378,0001.45%
Iguana Healthcare Management, LLC 125,000$3,474,0001.37%
EAM Investors, LLC 97,350$2,705,0000.43%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders